TGA changes continue to impact and sometimes baffle pharmacists

A number of recent decisions by the Therapeutic Goods Administration (TGA) are highly relevant to pharmacists in Australia. Firstly, the interim decision from the...

The pain of uncertainty: Managing pain without codeine

With over-the-counter (OTC) codeine products being upscheduled, pharmacists and pharmacy staff need to review and understand every patient’s pain. In doing so, there’s an...

Medicine shortage reports to be mandatory

New legislation passed on Monday night introduces mandatory reporting of shortages of all prescription medicines as well as other medicines deemed vital for public...

Complementary medicines: Rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by joint inflammation. The immune system attacks the tissue lining the joints (synovial membrane), causing...

Systemic corticosteroids for dyspnoea

The effectiveness of systemic corticosteroids for the management of dyspnoea in adults with advanced cancer. Dyspnoea affects almost 70% of advanced cancer patients at the...

New alliance between PSA and SHPA announced

At PSA19 this morning, it was revealed that a Memorandum of Understanding (MoU) was signed by PSA and the Society of Hospital Pharmacists of...